Canada reaches agreements for millions of doses of COVID-19 vaccine

The agreements raise the maximum doses of vaccines that can be given to Canadians to 190 million after similar agreements have been reached with Pfizer and Moderna.

The population of Canada is only 38 million.

“We have tried to pinpoint deals with many corporations because we don’t know who will be the first to expand a vaccine and where it will come from,” Prime Minister Justin Trudeau told a news convention in Montreal.

“We want to immunize as many Canadians as possible. “

Novavax’s NVX-CoV2373 candidate vaccine, found in phase 2 clinical trials, could be delivered in the same quarter of 2021, Ottawa and the company announced in a joint statement. The deal covers up to 76 million doses.

Johnson

Pfizer and Moderna had in the past agreed to deliver a minimum of 20 million doses and up to 50 million doses of their vaccines, lately in Phase 3 of the final trials and among the maximum developing complex, respectively.

The Novavax deal comes when the US government is in the middle of a nuclear union. But it’s not the first time It has awarded the Maryland-based company $1. 6 billion to fund the progression and manufacture of the vaccine, giving the US the right to do so. But it’s not the first time Precedence for the first hundred million doses.

Initial tests showed that his candidate “generally well tolerated” and provoked a “solid antibody response,” Novavax said.

“We are moving forward with the clinical progression of NVX-CoV2373 with a strong sense of urgency in our quest to deliver a vaccine to the world,” corporate President Stanley Erck said.

Leave a Comment

Your email address will not be published. Required fields are marked *